{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,4,9]],"date-time":"2025-04-09T16:31:10Z","timestamp":1744216270649},"reference-count":22,"publisher":"BMJ","issue":"6589","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["BMJ"],"published-print":{"date-parts":[[1987,7,4]]},"DOI":"10.1136\/bmj.295.6589.19","type":"journal-article","created":{"date-parts":[[2009,4,2]],"date-time":"2009-04-02T19:19:55Z","timestamp":1238699995000},"page":"19-22","source":"Crossref","is-referenced-by-count":50,"title":["Mortality and morbidity caused by measles in children with malignant disease attending four major treatment centres: a retrospective review."],"prefix":"10.1136","volume":"295","author":[{"given":"M M","family":"Gray","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"I M","family":"Hann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S","family":"Glass","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"O B","family":"Eden","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P M","family":"Jones","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R F","family":"Stevens","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1056\/NEJM198607313150509","article-title":"New directions in the treatment ofacute lymphoblastic leukaemia in children","volume":"315","author":"Mauer, A.M.","year":"1986","unstructured":"Mauer AM. New directions in the treatment ofacute lymphoblastic leukaemia in children. N Engl JMed 1986;315:316-7.","journal-title":"N Engl JMed"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1056\/NEJM197712292972602","article-title":"Successful prophylaxis for Pneumocystis carinii pneumonia","volume":"297","author":"Hughes, T.W.; Kuhn, S.; Chaudhary, S.","year":"1977","unstructured":"Hughes TW, Kuhn S, Chaudhary S, et al. Successful prophylaxis for Pneumocystis carinii pneumonia. N Englj Med 1977;297:1419-26.","journal-title":"N Englj Med"},{"key":"ref_3","first-page":"384","article-title":"Acyclovir prophylaxis against herpes virus infections in severely immunocompromised patients: randomised double blind trial","volume":"287","author":"Hann, I.M.; Prentice, H.G.; Blacklock, H.A.","year":"1983","unstructured":"Hann IM, Prentice HG, Blacklock HA, et al. Acyclovir prophylaxis against herpes virus infections in severely immunocompromised patients: randomised double blind trial. BrMedJ 1983;287: 384-8.","journal-title":"BrMedJ"},{"issue":"103","key":"ref_4","first-page":"413","article-title":"Attenuated measles vaccine in children with acute leukaemia","volume":"1962","author":"Mitus, A.; Holloway, A.; Evans, A.E.; Enders, J.F.","unstructured":"Mitus A, Holloway A, Evans AE, Enders JF. Attenuated measles vaccine in children with acute leukaemia. AmJ Dis Child 1962;103:413-8.","journal-title":"AmJ Dis Child"},{"key":"ref_5","first-page":"147","article-title":"Application of live attenuated measles and mumps vaccines in children with acute leukaemia","volume":"24","author":"Torigoe, S.; Hirai, S.; Oitani, K.","year":"1981","unstructured":"Torigoe S, Hirai S, Oitani K, et al. Application of live attenuated measles and mumps vaccines in children with acute leukaemia. Biken 1981;24:147-51.","journal-title":"Biken"},{"key":"ref_6","first-page":"901","article-title":"Immunoglobulin prophylaxis ofmeasles in acute lymphoblastic leukaemia","volume":"i:","author":"Kay, H.E.M.; Rankin, A.","year":"1984","unstructured":"Kay HEM, Rankin A. Immunoglobulin prophylaxis ofmeasles in acute lymphoblastic leukaemia. Lancet 1984;i:901-2.","journal-title":"Lancet"},{"key":"ref_7","first-page":"1562","article-title":"Atypical measles infections in children on immunosuppressive treatment","volume":"i:","author":"Pullan, C.R.; Noble, T.C.; Scott, D.J.; Wisniewski, K.; Gardner, P.S.","year":"1976","unstructured":"Pullan CR, Noble TC, Scott DJ, Wisniewski K, Gardner PS. Atypical measles infections in children on immunosuppressive treatment. Br MedJ 1976;i: 1562-5.","journal-title":"Br MedJ"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1056\/NEJM195910292611802","article-title":"Persistence of measles virus and depression of antibody formation in patients with giant cell pneumonia after measles","volume":"261","author":"Mitus, A.; Enders, J.F.; Craig, J.M.; Holloway, A.","year":"1959","unstructured":"Mitus A, Enders JF, Craig JM, Holloway A. Persistence of measles virus and depression of antibody formation in patients with giant cell pneumonia after measles. N Engl J Med 1959;261:882-9.","journal-title":"N Engl J Med"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1016\/S0140-6736(69)90789-2","article-title":"Immunosuppression and fatal measles","volume":"ii:","author":"Jones, H.E.","year":"1969","unstructured":"Jones HE. Immunosuppression and fatal measles. Lancet 1969;ii: 1255-6.","journal-title":"Lancet"},{"key":"ref_10","first-page":"1552","article-title":"Measles encephalitis during immunosuppressive treatment","volume":"i:","author":"Anonymous","year":"1976","unstructured":"Anonymous. Measles encephalitis during immunosuppressive treatment. [Editorial.] Br MedJ7 1976;i: 1552."},{"key":"ref_11","first-page":"315","article-title":"Possible interferon response in a child with measles encephalitis during immnunosuppression","volume":"16","author":"Simpson, R.; Eden, O.B.","year":"1984","unstructured":"Simpson R, Eden OB. Possible interferon response in a child with measles encephalitis during immnunosuppression. ScandJInfectDis 1984;16:315-9.","journal-title":"ScandJInfectDis"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"1592","DOI":"10.1001\/jama.1982.03320360042029","article-title":"Progress in measles elimination","volume":"247","author":"Hinman, A.R.; Eddins, D.L.; Kirby, C.D.","year":"1982","unstructured":"Hinman AR, Eddins DL, Kirby CD, et al. Progress in measles elimination. JAMA 1982;247: 1592-5.","journal-title":"JAMA"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1056\/NEJM198508293130910","article-title":"Measles-forgotten but not gone","volume":"313","author":"Katz, S.","year":"1985","unstructured":"Katz S. Measles-forgotten but not gone. NEngilMed 1985;313:577-8.","journal-title":"NEngilMed"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1136\/adc.58.1.3","article-title":"Measles immunisation: why have we failed?","volume":"58","author":"Campbell, A.G.M.","year":"1983","unstructured":"Campbell AGM. Measles immunisation: why have we failed?Arch Dis Child 1983;58:3-5.","journal-title":"Arch Dis Child"},{"key":"ref_15","first-page":"\"253","article-title":"Childhood immnpr hylaxis: achieemts in a Glasgow practice","volume":"16","author":"Ross, S.K.","year":"1983","unstructured":"Ross SK. Childhood immnpr hylaxis: achieemts in a Glasgow practice. Edinburgh: Scottish Home and Health Department, 1983:253-7. (Bulletin issued by chief medical officer, 41\/5.) 16 Fernandes V, Gill ON. Prevention of measles: vaccine efficacy and potential effectiveness of a vaccination programme on entry to school. BrMedJ 1985;291:1685.","journal-title":"BrMedJ; Prevention of measles: vaccine efficacy and potential effectiveness of a vaccination programme on entry to school"},{"key":"ref_16","first-page":"1616","article-title":"Measles immunisation","volume":"291","author":"Anderson, P.","year":"1985","unstructured":"Anderson P. Measles immunisation. BrMedJ 1985;291:1616.","journal-title":"BrMedJ"},{"key":"ref_17","first-page":"443","article-title":"Deaths from measlesin England and Wales","volume":"290","author":"Miller, C.L.","year":"1970","unstructured":"Miller CL. Deaths from measlesin England and Wales, 1970-83. BrMedJ 1985;290:443-4.","journal-title":"BrMedJ"},{"issue":"4","key":"ref_18","article-title":"Reasons for admission to hospital and cotplications in children with measles","volume":"300","author":"Walker, E.","year":"1983","unstructured":"Walker E. Reasons for admission to hospital and cotplications in children with measles. Edinburgh: Scottish Home and Health Department, 1983:300 4. (Bulletin issued by chief medical officer, 41\/6.)"},{"key":"ref_19","article-title":"Accepted","year":"1987","unstructured":"(Accepted 24 April 1987)"},{"key":"ref_20","article-title":"Introduction In September 1964 a Medical Research Council trial began in England and Wales to assess the immediate ardu long term protection afforded by measles vaccines. Over 36 000 children aged between 10 months and 2 years were randomly allocated either to receive live, Public Health Laboratory Service Communicable Disease Surveillance Centre, Colindale, London NW9","unstructured":"Introduction In September 1964 a Medical Research Council trial began in England and Wales to assess the immediate ardu long term protection afforded by measles vaccines. Over 36 000 children aged between 10 months and 2 years were randomly allocated either to receive live, Public Health Laboratory Service Communicable Disease Surveillance Centre, Colindale, London NW9"},{"key":"ref_21","article-title":"Four previous reports have been published. The first described the design of the trial and covered the initial six months of the follow up. ' The second and third reports gave the results at two years nine months2 and four years nine months,3 respectively, and the fourth reported 12 years after vaccination.4 The present report gives the results for a further nine years up to September 1985, 21 years after vaccination","unstructured":"Four previous reports have been published. The first described the design of the trial and covered the initial six months of the follow up. ' The second and third reports gave the results at two years nine months2 and four years nine months,3 respectively, and the fourth reported 12 years after vaccination.4 The present report gives the results for a further nine years up to September 1985, 21 years after vaccination."},{"key":"ref_22","article-title":"Subjects and methods As previously stated,2 3 the number of participants in the trial was reduced after the first nine months. Over 2000 children from each of the three vaccine groups were lost to follow up when five of the participating local authority areas withdrew from the trial to take part in a community investigation.5 In addition, because of an undertaking given at the outset of the trial, vaccination was offered to the control group after the first nine months; 7000 children were vaccinated and were therefore lost to follow up as controls","unstructured":"Subjects and methods As previously stated,2 3 the number of participants in the trial was reduced after the first nine months. Over 2000 children from each of the three vaccine groups were lost to follow up when five of the participating local authority areas withdrew from the trial to take part in a community investigation.5 In addition, because of an undertaking given at the outset of the trial, vaccination was offered to the control group after the first nine months; 7000 children were vaccinated and were therefore lost to follow up as controls."}],"container-title":["BMJ"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmj.295.6589.19","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,25]],"date-time":"2020-09-25T22:37:15Z","timestamp":1601073435000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.bmj.com\/lookup\/doi\/10.1136\/bmj.295.6589.19"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1987,7,4]]},"references-count":22,"journal-issue":{"issue":"6589","published-print":{"date-parts":[[1987,7,4]]}},"URL":"https:\/\/doi.org\/10.1136\/bmj.295.6589.19","relation":{},"ISSN":["0959-8138","1468-5833"],"issn-type":[{"value":"0959-8138","type":"print"},{"value":"1468-5833","type":"electronic"}],"subject":[],"published":{"date-parts":[[1987,7,4]]}}}